These findings align with the results obtained by Mesples et al. [28], who demonstrated that the levels of ICA, GAD, and IA2 antibodies were reduced in newly diagnosed T1D patients following autologous BMT, thereby suppressing autoimmune attack and pancreatic damage. Here, PTPRN is linked to type 1 diabetes mellitus.